1. Bliss GVS Pharma
stock logo

Bliss GVS Pharma Share Price

BLISSGVS

₹124.97+₹0.91 (0.73%) TodayLast updated on 05 Nov, 2024 | 11:01 IST

Bliss GVS Pharma Share Price Chart

Please wait...
  • About Bliss GVS Pharma
  • Fundamentals
  • Events
  • More

About Bliss GVS Pharma

Bliss GVS Pharma Financials

arrow
Market cap
Market Cap Switch₹1,306 Crs
Open
₹124.06
Close
₹124.06
Circuit range
₹148.87 - ₹99.24
Day range
₹123.16 - ₹125.90
Year range
₹92.15 - ₹149.60
Volume
1,35,686
Avg. traded
₹124.78
Revenue (12m)
₹800 Crs
Bliss GVS PharmaBliss GVS Pharma Limited is engaged in developing, manufacturing, and marketing pharmaceutical formulations. The Company’s product categories include pharma products, other healthcare products, and therapeutic index. Its pharma products include pharma products include capsules, creams, gels, ointments, dry powder for injection, effervescent tablets, eye/ear drops, nasal solution, lotions, lozenges, oral solids, and others. The Company’s other healthcare products include balm, nasal inhaler, solution, soap, roll on, shampoo, powder, spray, and petroleum jelly. Its brands include ANOMEX, ANOMEX DS, CONLAX 5/10, G - ALFENAC 100, GACET 80/125/170/250/500/1G, GMETH - 50/100, GSUNATE - 50/100/200, GVCAM - 7.5/15, GV-SOFT 1/2/3/4 G, LOFNAC - 12.5/25/50/100, MEFINOL, MELANEZ, MENINA - 25/100, TYRIDOL, VIGOTAMIN, COMIT 50, BG - CLIND, VAGID CL, ECOZOLE, GVGYL 500, GYNANFORT, GVGYL N, KLOVINAL, LONART, LONART FORTE, LONART Dispersible, FINMOL, GACET-500, NOVOGLIP-5, GVZOLE, and DOXYCYCLINE.

Bliss Gvs Pharma Key indicators

arrow
52 week high
₹149.60
52 week low
₹92.15
P/E ratio
20.88
P/B ratio
1.29
ROE
5.31%
ROCE
7.36%
Dividend yield
0.38%
Debt/Equity ratio
0.07
EPS
4.84

Learn more

Investment checklist: (2/6)
arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Bliss GVS Pharma Fundamentals

Bliss GVS Pharma Financial Ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

23.23%

Net profit margin

8.36%

ROE

5.31%

ROA

4.43%

ROCE

7.36%

Learn more

Bliss GVS Pharma Shareholder returns

arrow
1 day
-2.31%
1 week
+5.02%
1 month
-4.77%
3 months
+6.32%
1 year
+23.69%
3 years
+18.43%
5 years
-13.79%

Bliss Gvs Pharma Share Price history

arrow
DayOpenCloseChange %
Mon, Nov 4 2024
₹128.40
₹124.06
-2.31%
Fri, Nov 1 2024
₹123.80
₹127.00
+2.79%
Thu, Oct 31 2024
₹125.50
₹123.55
-1.92%
Wed, Oct 30 2024
₹121.35
₹125.97
+1.59%
Tue, Oct 29 2024
₹116.30
₹124.00
+4.97%
Mon, Oct 28 2024
₹110.39
₹118.13
+8.45%
Fri, Oct 25 2024
₹117.35
₹108.93
-12.45%
Thu, Oct 24 2024
₹127.00
₹124.42
-1.89%

Bliss GVS Pharma Shareholding Pattern

arrow

Promoters (34.9%)

Mutual Funds (0%)

Retail and other (45.27%)

Foreign institutions-FII (13.24%)

Other domestic institutions (6.59%)

Retail and other

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹0.5/share

    Ex date 18 Jul 2024

    expand tab
  • Dividend • ₹0.5/share

    Ex date 12 Jul 2023

    expand tab
  • Dividend • ₹0.5/share

    Ex date 20 Jun 2022

    expand tab

Learn more

FAQs on Bliss GVS Pharma